ibogaine has been researched along with gyki 52466 in 1 studies
| Studies (ibogaine) | Trials (ibogaine) | Recent Studies (post-2010) (ibogaine) | Studies (gyki 52466) | Trials (gyki 52466) | Recent Studies (post-2010) (gyki 52466) |
|---|---|---|---|---|---|
| 445 | 8 | 136 | 312 | 0 | 38 |
| Protein | Taxonomy | ibogaine (IC50) | gyki 52466 (IC50) |
|---|---|---|---|
| Glutamate receptor 1 | Rattus norvegicus (Norway rat) | 10 | |
| Glutamate receptor 2 | Rattus norvegicus (Norway rat) | 10 | |
| Glutamate receptor 3 | Rattus norvegicus (Norway rat) | 10 | |
| Glutamate receptor 4 | Rattus norvegicus (Norway rat) | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Molliver, ME; O'Hearn, E | 1 |
1 other study(ies) available for ibogaine and gyki 52466
| Article | Year |
|---|---|
Administration of a non-NMDA antagonist, GYKI 52466, increases excitotoxic Purkinje cell degeneration caused by ibogaine.
Topics: Animals; Benzodiazepines; Dose-Response Relationship, Drug; Drug Synergism; Excitatory Amino Acid Antagonists; Glutamic Acid; Ibogaine; Male; Nerve Degeneration; Neurotoxins; Olivary Nucleus; Purkinje Cells; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Synapses; Synaptic Transmission; Up-Regulation | 2004 |